![]() | ||
---|---|---|
![]() The new 70,000-square-foot expansion in Verona will allow MilliporeSigma to facilitate complex, large-scale manufacturing of increasingly potent compounds, including Highly Potent Active Pharmaceutical Ingredient (HPAPI) and Antibody-Drug Conjugate (ADC). Both compounds have the potential to treat cancer. The expansion project is slated to break ground this spring and completed by mid-2022.... ...more | ||
Share this article on you social outlets | ||
Our Sponsors - - Volume: 9 - WEEK: 13 Date: 3/25/2021 8:13:39 AM - |